Norwegian biotech firm Vestland Pharma has secured NOK 12 million in funding from venture capital group Sarsia and seafood giant Coast Seafood to fast-track the launch of its new natural salmon lice treatment.
Source link
About us
At Blue Economy, we are dedicated to bringing you the latest news, insights, and developments in the world of water, kelp, and seaweed farms. Our mission is to inform, educate, and inspire our readers about the immense potential and importance of sustainable aquaculture.
Must Read
Global Seaweed Coalition secures critical funding to continue its operations
The Global Seaweed Coalition (GSC) is proud to...
New partnership advances humane culling practices in smolt production
Ace Aquatec has signed a collaboration agreement with...
Subscribe
© 2024 Blue Economy. All Rights Reserved.